Bloom S R, Polak J M
Scand J Gastroenterol Suppl. 1982;74:93-103.
A number of human diseases with intestinal adaptation have been investigated, including acute infective diarrhoea, intestinal resection, jejuno-ileal bypass, coeliac disease, tropical sprue, chronic pancreatitis and cystic fibrosis. In all, the newly isolated hormone enteroglucagon appeared to be elevated in proportion to the degree of adaptation. In rats after gut resection and cold adaptation, enteroglucagon was also elevated and the degree of elevation correlated closely with the crypt cell production rate (CCPR). Chronic administration of somatostatin suppressed both enteroglucagon and CCPR, while bombesin stimulated both. A crude preparation of enteroglucagon was found to directly stimulate DNA synthesis in enterocyte cultures. It is thus concluded that, at present, the most likely candidate for the humoral component of intestinal adaptation is the hormonal peptide enteroglucagon.
人们已经对多种具有肠道适应性的人类疾病进行了研究,包括急性感染性腹泻、肠道切除术、空肠回肠旁路术、乳糜泻、热带口炎性腹泻、慢性胰腺炎和囊性纤维化。总体而言,新分离出的激素肠高血糖素似乎会随着适应程度的增加而升高。在大鼠进行肠道切除和冷适应后,肠高血糖素也会升高,且升高程度与隐窝细胞生成率(CCPR)密切相关。长期给予生长抑素会抑制肠高血糖素和CCPR,而蛙皮素则会刺激二者。研究发现,肠高血糖素的粗制品可直接刺激肠上皮细胞培养物中的DNA合成。因此得出结论,目前,肠道适应性体液成分最可能的候选者是激素肽肠高血糖素。